Can gout management guidelines be solely evidence based?

被引:2
作者
Bardin, Thomas [1 ,2 ]
Richette, Pascal [1 ,2 ]
机构
[1] Hop Lariboisiere, Dept Rheumatol, Paris, France
[2] Univ Paris, INSERM, Unit U1132, Paris, France
关键词
D O I
10.1038/s41584-020-0471-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ACR has published an update to its guideline on gout management, which was mostly based on the results of randomized controlled trials (RCTs). Although rigorous, the methodology used for these recommendations can be called into questioned given the lack of robust data from RCTs on all aspects of gout.
引用
收藏
页码:479 / 480
页数:2
相关论文
共 9 条
[1]   Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) [J].
Dalbeth, Nicola ;
Bardin, Thomas ;
Doherty, Michael ;
Liote, Frederic ;
Richette, Pascal ;
Saag, Kenneth G. ;
So, Alexander K. ;
Stamp, Lisa K. ;
Choi, Hyon K. ;
Terkeltaub, Robert .
NATURE REVIEWS RHEUMATOLOGY, 2017, 13 (09) :561-568
[2]   2020 American College of Rheumatology Guideline for the Management of Gout [J].
FitzGerald, John D. ;
Dalbeth, Nicola ;
Mikuls, Ted ;
Brignardello-Petersen, Romina ;
Guyatt, Gordon ;
Abeles, A. M. ;
Gelber, Allan C. ;
Harrold, Leslie R. ;
Khanna, Dinesh ;
King, Charles ;
Levy, Gerald ;
Libbey, Caryn ;
Mount, David ;
Pillinger, Michael H. ;
Rosenthal, Ann ;
Singh, Jasvinder A. ;
Sims, James Edward ;
Smith, Benjamin J. ;
Wenger, Neil S. ;
Bae, Sangmee Sharon ;
Danve, Abhijeet ;
Khanna, Puja P. ;
Kim, Seoyoung C. ;
Lenert, Aleksander ;
Poon, Samuel ;
Qasim, Anila ;
Sehra, Shiv T. ;
Sharma, Tarun Sudhir Kumar ;
Toprover, Michael ;
Turgunbaev, Marat ;
Zeng, Linan ;
Zhang, Mary Ann ;
Turner, Amy S. ;
Neogi, Tuhina .
ARTHRITIS & RHEUMATOLOGY, 2020, 72 (06) :879-895
[3]   Discontinuing febuxostat might cause more deaths than continuing febuxostat: the untold story from the CARES trial [J].
Ghang, Byeongzu ;
Ahn, Soo Min ;
Kim, Jinseok ;
Kim, Yong-Gil ;
Lee, Chang-Keun ;
Yoo, Bin .
RHEUMATOLOGY, 2020, 59 (06) :1439-1440
[4]   Global epidemiology of gout: prevalence, incidence and risk factors [J].
Kuo, Chang-Fu ;
Grainge, Matthew J. ;
Zhang, Weiya ;
Doherty, Michael .
NATURE REVIEWS RHEUMATOLOGY, 2015, 11 (11) :649-662
[5]   Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia [J].
MacDonald, Thomas M. ;
Ford, Ian ;
Nuki, George ;
Mackenzie, Isla S. ;
De Caterina, Raffaele ;
Findlay, Evelyn ;
Hallas, Jesper ;
Hawkey, Christopher J. ;
Ralston, Stuart ;
Walters, Matthew ;
Webster, John ;
McMurray, John ;
Ruiz, Fernando Perez ;
Jennings, Claudine G. .
BMJ OPEN, 2014, 4 (07)
[6]   2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy [J].
Pascart, Tristan ;
Latourte, Augustin ;
Flipo, Rene-Marc ;
Chales, Gerard ;
Coblentz-Baumann, Laurence ;
Cohen-Solal, Alain ;
Ea, Hang-Korng ;
Grichy, Jacques ;
Letayernier, Emmanuel ;
Liote, Frederic ;
Ottaviani, Sebastien ;
Sigwalt, Pierre ;
Vandecandelaere, Guy ;
Richette, Pascal ;
Bardin, Thomas .
JOINT BONE SPINE, 2020, 87 (05) :395-404
[7]  
Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]
[8]   Achievements and Limitations of Evidence-Based Medicine [J].
Sheridan, Desmond J. ;
Julian, Desmond G. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (02) :204-213
[9]   Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout [J].
White, William B. ;
Saag, Kenneth G. ;
Becker, Michael A. ;
Borer, Jeffrey S. ;
Gorelick, Philip B. ;
Whelton, Andrew ;
Hunt, Barbara ;
Castillo, Majin ;
Gunawardhana, Lhanoo .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13) :1200-1210